Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...

Concerns have also been raised about the proportion of men who were only diagnosed after their disease had spread ...

Niraparib is a “maintenance” drug approved to keep certain types of cancer from coming back, including ovarian cancer, ...

Experts argue it's never too late to quit smoking, and a new study says that applies to people with late-stage cancer as well. Patients with advanced cancer gained nearly a full year of additional ...

Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers.

According to reports circulating last week, the Government is set to kick into the long grass the proposal for a national ...